


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:50:21Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406848" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406848</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>bmjo</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="pmc-domain-id">1609</journal-id><journal-id journal-id-type="pmc-domain">bmjo</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406848</article-id><article-id pub-id-type="pmcid-ver">PMC12406848.1</article-id><article-id pub-id-type="pmcaid">12406848</article-id><article-id pub-id-type="pmcaiid">12406848</article-id><article-id pub-id-type="pmid">40887114</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2024-098248</article-id><article-id pub-id-type="publisher-id">bmjopen-2024-098248</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Obstetrics and Gynaecology</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1845</subject><subject>1506</subject></subj-group></article-categories><title-group><article-title>Maternal, fetal and neonatal adverse outcomes associated with gestational diabetes: a prospective cohort study at King Faisal Hospital, Kigali</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0007-4561-3934</contrib-id><name name-style="western"><surname>Nshimiyumuremyi</surname><given-names initials="E">Emmanuel</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nigatu</surname><given-names initials="BK">Balkachew Kabtyimer</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7071-520X</contrib-id><name name-style="western"><surname>Amberbir</surname><given-names initials="A">Alemayehu</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>J Gilson</surname><given-names initials="G">George</given-names></name><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Manzi</surname><given-names initials="S">Subira</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nkubito</surname><given-names initials="V">Valens</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gashema</surname><given-names initials="H">Heritier</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gibia</surname><given-names initials="S">Sandrine</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Temesgen</surname><given-names initials="F">Fikremelekot</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sitini</surname><given-names initials="B">Bertin</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mugaba</surname><given-names initials="M">Michael</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Byiringiro</surname><given-names initials="JP">Jean Paul</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><aff id="aff1"><label>1</label><institution content-type="department">Department of Obstetrics and Gynecology</institution>, <institution>Kigali University Teaching Hospital</institution>, <addr-line content-type="city">Kigali</addr-line>, <country>Rwanda</country></aff><aff id="aff2"><label>2</label><institution content-type="department">Department of Obstetrics and Gynecology</institution>, <institution>King Faisal Hospital</institution>, <addr-line content-type="city">Kigali</addr-line>, <country>Rwanda</country></aff><aff id="aff3"><label>3</label><institution content-type="department">Department of Research</institution>, <institution>University of Global Health Equity</institution>, <addr-line content-type="city">Kigali</addr-line>, <country>Rwanda</country></aff><aff id="aff4"><label>4</label><institution content-type="department">Former Human Resource for Health</institution>, <institution>University Teaching Hospital of Butare</institution>, <addr-line content-type="city">Butare</addr-line>, <country>Rwanda</country></aff><aff id="aff5"><label>5</label><institution content-type="department">Department of Obstetrics and Gynecology</institution>, <institution>Rwanda Military Referral and Teaching Hospital</institution>, <addr-line content-type="city">Kigali</addr-line>, <country>Rwanda</country></aff></contrib-group><author-notes><corresp id="cor1">Dr Emmanuel Nshimiyumuremyi; <email xlink:href="nshimanu@gmail.com">nshimanu@gmail.com</email></corresp><fn fn-type="COI-statement" id="fn5"><p>None declared.</p></fn></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>31</day><month>8</month><year>2025</year></pub-date><volume>15</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">494363</issue-id><elocation-id>e098248</elocation-id><history><date date-type="received"><day>20</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>31</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>31</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:&#160;<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="bmjopen-15-8.pdf"/><self-uri xlink:title="pdf" xlink:href="bmjopen-15-8.pdf"/><abstract><sec><title> Abstract</title></sec><sec><title>Objectives</title><p>The study aimed to evaluate the cumulative incidence of gestational diabetes (GD) among pregnant women receiving antenatal care at the King Faisal Hospital (KFH) in Kigali, Rwanda, using the criteria established by the International Association of Diabetes and Pregnancy Study Groups and endorsed by the WHO in 2013.</p></sec><sec><title>Design</title><p>Prospective cohort study.</p></sec><sec><title>Setting</title><p>KFH-Kigali, Rwanda.</p></sec><sec><title>Participants</title><p>A total of 284 pregnant women were enrolled between May 2023 and April 2024.</p></sec><sec><title>Results</title><p>The cumulative incidence rate of GD was 19.5% (95% CI 15% to 24.6%). Most participants (78%) were from Kigali City. Most participants belong to high-income households (96.5%) and were employed (85%). Risk factors associated with the development of GD included increased body mass index (adjusted relative risk (aRR) 3.2; 95%&#8201;CI 2.02 to 5.3), a history of macrosomia (aRR 4.9; 95%&#8201;CI 1.6 to 12) and family history of type 2 diabetes (aRR 4.6; 95%&#8201;CI 1.3 to 14). Women diagnosed with GD had a significantly higher risk of adverse outcomes, including pre-eclampsia and gestational hypertension (aRR 6.7; 95%&#8201;CI 1.7 to 26) polyhydramnios (aRR 6.4; 95%&#8201;CI 1.94 to 8.9), postpartum haemorrhage (aRR 3; 95%&#8201;CI 2.7 to 3.9) and caesarean delivery (aRR 4.9; 95%&#8201;CI 1.6 to 9.1). Neonatal complications were also common in infants born to mothers with GD, including neonatal hypoglycaemia (aRR 2.2; 95%&#8201;CI 1.2 to 4.5), neonatal intensive care unit admission (aRR 1.7; 95%&#8201;CI 1 to 4.6) and macrosomia (aRR 2.3; 95%&#8201;CI 1.01 to 3.5).</p></sec><sec><title>Conclusions</title><p>This study provides important data on the cumulative incidence of GD at the KFH in Rwanda and highlights the key maternal and neonatal factors and adverse outcomes associated with the condition. Given the growing global burden of obesity and diabetes, further research and public health education are essential for mitigating the double burden of GD on maternal and neonatal health.</p></sec></abstract><kwd-group><kwd>Prenatal diagnosis</kwd><kwd>DIABETES &amp; ENDOCRINOLOGY</kwd><kwd>Diabetes in pregnancy</kwd><kwd>OBSTETRICS</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002382</institution-id><institution>King Faisal Specialist Hospital and Research Centre</institution></institution-wrap></funding-source><award-id>KFH/249</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="disclaimer"><p>The King Faisal Hospital-Kigali Foundation had no role in the design, management, data collection, analyses or interpretation of the data or in the writing of the manuscript or the decision to submit for publication.</p></notes></front><body><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>STRENGTHS AND LIMITATIONS OF THIS STUDY</title></caption><list list-type="bullet" list-content="ul"><list-item><p>The study employed a prospective cohort design.</p></list-item><list-item><p>The screening for GD was conducted in accordance with WHO 2013 guidelines.</p></list-item><list-item><p>Venous blood samples were analysed immediately after collection, ensuring timely and accurate results.</p></list-item><list-item><p>Data on participants&#8217; prepregnancy body mass index were not available.</p></list-item><list-item><p>To generalise the findings to the broader population, similar studies should be conducted in other healthcare facilities across the country.</p></list-item></list></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p> Gestational diabetes (GD) is a form of carbohydrate intolerance with onset during pregnancy, and it remains a public health concern in low-income and middle-income countries, contributing significantly to maternal and neonatal mortality and morbidity.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> The diagnosis of GD has been in practice for over five decades and is typically made by using a 75 g oral glucose tolerance test (OGTT), while the diagnostic blood sugar thresholds have undergone minor revisions over time, data from the Hyperglycaemia and Adverse Pregnancy Outcome study demonstrated that elevated blood glucose levels following a 75&#8201;g OGTT are associated with adverse neonatal and maternal outcomes, including a positive correlation between increased maternal glucose levels and the risk of developing an infant with a birth weight above the 90th percentile, primary caesarean delivery, neonatal hypoglycaemia, elevated cord serum C-peptide (above the 90th percentile), pre-eclampsia, preterm delivery, shoulder dystocia and neonatal intensive care unit (NICU) admission.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref></p><p>Approximately 371&#8201;million people suffer from diabetes mellitus (DM) worldwide, and it is projected that this number will double in Africa alone by 2030, with women accounting for 50% of all cases.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref></p><p>The global prevalence of GD ranges from 1% to 28%, depending on the population and diagnostic criteria used. When using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria, the estimated global prevalence is 14.7%, the highest prevalence is reported in South-East Asia (25%), while the lowest is in North America and the Caribbean (10.4%). Notably, approximately 90% of GD cases occur in developing countries.<xref rid="R3" ref-type="bibr"><sup>3 4</sup></xref></p><p>In sub-Saharan Africa, GD remains a significant issue related to the maternal and child health issue, with an estimated regional prevalence of 14%.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref> Studies have shown wide variability in the prevalence of GD across different African subregions, largely due to differences in screening protocols, diagnostic criteria and population characteristics.</p><p>The prevalence of GD is 6% in East Africa and 14% in West Africa. The prevalence rate varies further within the countries, for example, 8.3% in Rwanda, 5.9% in Tanzania and 3.7% in Ethiopia.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref></p><p>The lack of a uniform global approach for screening and diagnosing GD has led to inconsistencies in prevalence estimates between countries. Nonetheless, in 2013, the WHO and the American Diabetes Association endorsed the IADPSG recommendations to standardise diagnostic criteria.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref> In 2018, a study conducted in Arusha, Tanzania, in 2018 reported a GD prevalence of 13%. Significant associations were observed between GD and higher body fat percentage (aOR 1.3; 95%&#8201;CI 1.2 to 1.4), family history of type 2 DM (aOR 6.9; 95%&#8201;CI 3.1 to 15.5), history of delivering a macrosomic baby (&#8805;4&#8201;kg) (adjusted relative risk, aRR 2.3; 95%&#8201;CI 1.0 to 5.2) and mid-upper arm circumference &#8805;28&#8201;cm (aOR 1.2; 95%&#8201;CI 1.0 to 1.3).<xref rid="R6" ref-type="bibr"><sup>6</sup></xref> While genetic predisposition is unlikely to have changed significantly over the past few decades, the sharp increase in the prevalence of GD suggests that environmental and lifestyle factors are the primary drivers of this emerging epidemic. A study conducted in Ethiopia found that 61.5% of women diagnosed with GD had low levels of physical activity, and 13.2% had inadequate dietary intake. Similarly, a study conducted in Tanzania reported a marked disparity in GD prevalence between urban and rural areas, with rates of 8.4% and 1%, respectively.<xref rid="R1" ref-type="bibr"><sup>1 7</sup></xref></p><p>Recent studies have suggested that modern wheat varieties, bred for higher yield and baking qualities, may contain higher levels of proinflammatory proteins (modern gluten) than those of traditional wheat. These compounds have been shown to trigger innate immune responses, promoting intestinal inflammation and systemic low-grade inflammation, inflammation and insulin resistance. Chronic inflammation is a known mediator of insulin resistance, which underpins the pathophysiology of GD and wheat-based diets in urban Africa. The increased consumption of refined wheat flour (eg, white bread, chapati, pastries) in urban areas in Tanzania is replacing traditional high-fibre diets, potentially contributing to rising prevalence of DM.<xref rid="R8" ref-type="bibr"><sup>8 9</sup></xref></p><p>We have limited data on the consumption of sugar beverages and the development of GD in Africa. A study of pregnant women diagnosed with GD found a median daily intake of 17.9 mL of sugar-sweetened beverage and 4 g of added sugar, and 63%&#8201;women reported drinking up to half a small glass (125&#8201;mL of sugar-sweetened beverages per day.<xref rid="R10" ref-type="bibr"><sup>10</sup></xref></p><p>The study aimed to determine the cumulative incidence of GD and its association with sociodemographic characteristics, as well as maternal, fetal and neonatal outcomes among pregnant women visiting antenatal care (ANC) at the King Faisal Hospital (KFH), Kigali between 24 and 28 weeks of gestation.</p><p>Understanding the interplay between these factors is crucial for developing targeted public health strategies. Further research is needed to investigate the causes of the rising prevalence of GD in African settings, including sociocultural dietary changes, urbanisation and the potential proinflammatory role of modern wheat consumption. These insights can inform context-specific preventive and management approaches tailored to Rwanda and Africa.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2-1"><title>Study designs</title><p>This was a prospective follow-up study designed to assess the cumulative incidence of GD, evaluate its association with various maternal risk factors and examine maternal, fetal and neonatal outcomes.</p></sec><sec id="s2-2"><title>Study site and duration</title><p>The study was conducted at the KFH from 15 May 2023 to 15 April 2024. The recruitment phase lasted for 8&#8201;months, followed by a 4-month follow-up period.</p></sec><sec id="s2-3"><title>Sample size and sampling strategy</title><p>Participants were recruited using a consecutive sampling strategy. The minimum required sample size was calculated using the following equation:</p><p>
<inline-formula>
<mml:math id="M1" overflow="scroll"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mi>Z</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#8722;</mml:mo><mml:mi>p</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mfrac></mml:mrow></mml:mstyle></mml:math>
</inline-formula>
</p><p>where: n=the minimum required sample size.</p><p>Z<sup>2</sup>=the standard normal value corresponding to 95% CI equal to 1.96.</p><p>p=the estimated proportion of patients with GD in Goma City, Democratic Republic of Congo as 21%.</p><p>e=level of precision set at 5%.</p><p>Thus,</p><p>
<inline-formula>
<mml:math id="M2" overflow="scroll"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>3.84</mml:mn><mml:mtext>&#160;</mml:mtext><mml:mfrac><mml:mrow><mml:mn>0.21</mml:mn><mml:mtext>&#160;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#8722;</mml:mo><mml:mn>0.21</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mn>0.0025</mml:mn></mml:mfrac><mml:mo>=</mml:mo><mml:mn>254.8</mml:mn><mml:mo>&#8776;</mml:mo><mml:mn>255</mml:mn></mml:mrow></mml:mstyle></mml:math>
</inline-formula>
</p><p>To account for potential non-responders and dropouts, 10% was added to the calculated sample size, resulting in a final target of approximately 280 participants.</p></sec><sec id="s2-4"><title>Study participants&#8217; recruitment and follow-up plan</title><p>Pregnant women visiting ANC between 24 and 28 weeks of gestation were enrolled in this study. Most were covered by the national health insurance, while the remainder had private insurance coverage. Screening and diagnosis of GD were performed using the one-step approach recommended by the WHO in 2013. We conducted screening over an 8-month period, and the follow-up was 4 months. During the final month of recruitment, we enrolled participants at 24 weeks of gestation and followed them for an additional 4&#8201;months. This follow-up period was carefully planned to ensure that all participants would have delivered by the end of the study, enabling the assessment of maternal, fetal and neonatal outcomes. According to our institutional protocol, no pregnancies extend beyond 41 weeks of gestation.</p><p>Women diagnosed with GD and those with normal (OGTT) results were included in the study and followed up until delivery or until another obstetric event occurred.</p><p>All participants received dietary counselling and treatment as necessary. This study aimed to compare the outcomes between women with and without GD to assess the association between maternal sociodemographic and obstetric characteristics (independent variables) and the development of GD (primary outcome).</p><p>Follow-ups were conducted by the principal investigator and trained research assistants. Participants&#8217; contact information was collected, and monthly follow-up visits were scheduled based on their estimated dates of delivery. Recruitment occurred over an 8-month period.</p><sec id="s2-4-1"><title>Inclusion criteria</title><p>We conducted a universal screening for GD mellitus (GDM) among all pregnant women attending outpatient consultations at the KFH between 24 and 28 weeks of gestation. Screening continued until the required sample size was achieved. Participants were diagnosed with GD if they had at least one abnormal glucose value meeting or exceeding the following thresholds: fasting glucose &#8805;92&#8201;mg/dL, 1-hour glucose &#8805;180&#8201;mg/dL or 2-hour glucose &#8805;153&#8201;mg/dL.</p><p>Inclusion criteria comprised all pregnant women who visited ANC at the KFH, signed informed consent and underwent a 75&#8201;g OGTT between 24 and 28 weeks of gestation.</p></sec><sec id="s2-4-2"><title>Exclusion criteria</title><p>Participants were excluded if they met any of the following:</p><list list-type="bullet" list-content="ul"><list-item><p>A history of pregestational DM or documented diabetes during pregnancy from medical records.</p></list-item><list-item><p>Declined to provide informed consent.</p></list-item><list-item><p>Underwent GD screening before 24 weeks or after 28 weeks of gestation.</p></list-item><list-item><p>Met criteria for diabetes in pregnancy, including:</p><list list-type="bullet" list-content="ul"><list-item><p>Fasting blood glucose &#8805;126&#8201;mg/dL (7.0&#8201;mmol/L).</p></list-item><list-item><p>2-hour glucose &#8805;200&#8201;mg/dL (11.1&#8201;mmol/L) after a 75&#8201;g OGTT.</p></list-item><list-item><p>Random blood glucose &#8805;200&#8201;mg/dL (11.1&#8201;mmol/L).</p></list-item><list-item><p>Glycated haemoglobin &#8805;6.5%.</p></list-item></list></list-item></list><p>Women diagnosed with diabetes during pregnancy were excluded and referred to an endocrinologist for further management.</p></sec></sec><sec id="s2-5"><title>Data collection and management</title><p>Data were collected from pregnant women visiting ANC at 24&#8211;28 weeks of gestation at the Department of Obstetrics and Gynaecology, KFH. A structured questionnaire was used to collect sociodemographic and obstetric history data through face-to-face interviews. The eligible participants were subsequently referred for laboratory testing and GD screening.</p><p>Participants were followed up to assess the relationship between GD and maternal, fetal and neonatal outcomes. We evaluated associations between maternal characteristics (independent variables) and the development of GD (primary outcome), as well as the impact of GD on adverse maternal and neonatal outcomes (secondary outcomes) by comparing those with a diagnosis of GD and those who were screened negative for GD.</p><p>We examined the effects of GD on the development of adverse maternal, fetal and neonatal outcomes (secondary outcomes).</p><p>Maternal outcomes collected in the two groups were pre-eclampsia, induction of labour, caesarean delivery, operative vaginal delivery, preterm delivery, shoulder dystocia, fetal death, operative vaginal delivery, polyhydramnios and postpartum haemorrhage (PPH).</p><p>The fetal and neonatal outcomes collected in the two groups were macrosomia, brachial paralysis, fetal demise, stillbirth, low Appearance Pulse Grimace Activity Respiration score below 5/10 at 10&#8201;min, hypoglycaemia, NICU admission and neonatal death.</p><p>The data were entered into the EpiData database and exported to STATA V.18 software for analysis. Data cleaning and coding were performed post-entry to identify and correct any inconsistencies. Missing data were handled using a complete-case analysis approach, in which only participants with complete data were included.</p><p>Single sensitivity analysis was conducted to test the robustness of the primary findings, assess the impact of methodological changes and account for unmeasured confounding variables.</p></sec><sec id="s2-6"><title>Data management</title><p>The gathered data were entered into the EpiData database and subsequently exported to STATA V.18 software for analysis.</p><p>Data entry errors were checked and adjusted during data cleaning and coding, which were performed after data entry.</p><p>Missing data were handled using a complete case analysis approach, where only the participants with complete data were included and those with missing data were excluded.</p><p>The quality of the results and conclusions from the primary data analysis and the effect of any change during data collection, change in the methodology, unmeasured variables and handling of missing data were tested using the single sensitivity analysis to draw the final conclusions.</p></sec><sec id="s2-7"><title>Patients and public involvement</title><p>Patients and the general public were not involved in the design, recruitment or conduct of this study. In this observational study using routinely collected clinical data of individuals attending ANC and delivery at the KFH, Kigali, there was no direct patient or public involvement. However, participants were informed of the study objectives and provided consent for the use of their anonymised data for research purposes.</p></sec><sec id="s2-8"><title>Data analysis</title><p>Descriptive data are presented as follows: categorical data are displayed using frequencies and proportions in tables and charts, whereas continuous data are summarised using means and medians, along with their SDs or IQRs.</p><p>Bivariate analysis was performed using the &#967;2 test, while multivariate analysis was carried out through multiple logistic regression, adjusting for confounding factors, to evaluate the relationship between the dependent variable and potential predictor variables. Associations were considered statistically significant if p&lt;0.05&#8201;and 95% CI did not include one.</p></sec><sec id="s2-9"><title>Sensitivity and validity of the study</title><p>The internal validity of our study was controlled after data collection, the impact of confounding factors in our study was adjusted statistically by using regression analysis models, where the effect of potential confounding factors on the outcome variables was assessed through the results of the regression analysis.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><p>Between April 2023 and May 2024, 282 pregnant women were screened for GD over an 8-month period, with a subsequent follow-up period of 4&#8201;months. Of these, 55 participants were diagnosed with GD, yielding a cumulative incidence rate of 19.5% (95% CI 15.0% to 24.6%). In this study, 304 pregnant women at 24 and 28 weeks of gestation were recruited between May 2023 and April 2024. Nine women declined to sign the consent form and were excluded from the study. The remaining 295 participants underwent the 75&#8201;g OGTT. Seven women had fasting blood glucose levels &gt;125&#8201;mg/dL and were diagnosed with DM during pregnancy; they were also excluded from the study.</p><p>Further, a total of 288&#8201;women were screened and followed up until April 2024; however, 6 participants were lost to follow-up and 282 pregnant women were included in the final analysis, yielding a response rate of 95%. Among them, 55 were diagnosed with GD, while 227 had normal blood glucose levels (<xref rid="F1" ref-type="fig">figure 1</xref>).</p><fig position="float" id="F1" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><title>Flow diagram of participants through the study period. ANC, antenatal care; GD, gestational diabetes; KFH, King Faisal Hospital.</title></caption><graphic position="float" orientation="portrait" xlink:href="bmjopen-15-8-g001.jpg"/></fig><sec id="s3-1"><title>Socioeconomic and demographic characteristics of study participants</title><p>The mean age and body mass index (BMI) of the participants were 30.7 years (&#177;4.9 SD) and 28.5&#8201;kg/m&#178; (&#177;5.3&#8201;SD), respectively. The mean gestational age at delivery was 38.4 weeks (&#177;1.6&#8201;SD), and the mean birth weight was 3.2&#8201;kg (&#177;0.603&#8201;SD). Differentiating the regional origin of participants is important, as geographical variation often reflects disparities in healthcare access, lifestyle patterns (such as diet and physical activity) and socioeconomic conditions, all of which may affect maternal health outcomes. Although the majority of participants in this study (77.7%) were residents of Kigali City, examining whether women from other regions exhibit distinct risk profiles for GDM remains relevant for understanding potential geographical determinants of GDM risk. Over 40% of women were obese, and the average BMI was in the overweight range (28.5&#8201;kg/m&#178;), suggesting a high burden of excess weight even in affluent, educated populations (<xref rid="T1" ref-type="table">table 1</xref>).</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><title>Socioeconomic and demographic characteristics of pregnant women visiting ANC at KFH, May 2023&#8211;April 2024 (n=282)</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2" colspan="1">N</th><th align="left" valign="bottom" rowspan="1" colspan="1">Non-GD, n (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">GD, n (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Total (%)</th><th align="left" valign="bottom" rowspan="2" colspan="1">Test</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">227 (80.5)</th><th align="left" valign="top" rowspan="1" colspan="1">55 (19.5)</th><th align="left" valign="top" rowspan="1" colspan="1">282 (100.0)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, years</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;&lt;24</td><td align="left" valign="top" rowspan="1" colspan="1">10 (4.4)</td><td align="left" valign="top" rowspan="1" colspan="1">3 (5.5)</td><td align="left" valign="top" rowspan="1" colspan="1">13 (4.6)</td><td align="left" valign="top" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;24&#8211;34</td><td align="left" valign="top" rowspan="1" colspan="1">172 (75.8)</td><td align="left" valign="top" rowspan="1" colspan="1">29 (52.7)</td><td align="left" valign="top" rowspan="1" colspan="1">201 (71.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;&gt;34</td><td align="left" valign="top" rowspan="1" colspan="1">45 (19.8)</td><td align="left" valign="top" rowspan="1" colspan="1">23 (41.8)</td><td align="left" valign="top" rowspan="1" colspan="1">68 (24.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Area of residence</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">0.129</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Kigali city</td><td align="left" valign="top" rowspan="1" colspan="1">177 (78.0)</td><td align="left" valign="top" rowspan="1" colspan="1">42 (76.4)</td><td align="left" valign="top" rowspan="1" colspan="1">219 (77.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Eastern Province</td><td align="left" valign="top" rowspan="1" colspan="1">23 (10.1)</td><td align="left" valign="top" rowspan="1" colspan="1">3 (5.5)</td><td align="left" valign="top" rowspan="1" colspan="1">26 (9.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Western Province</td><td align="left" valign="top" rowspan="1" colspan="1">5 (2.2)</td><td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="left" valign="top" rowspan="1" colspan="1">5 (1.8)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Northern Province</td><td align="left" valign="top" rowspan="1" colspan="1">10 (4.4)</td><td align="left" valign="top" rowspan="1" colspan="1">5 (9.1)</td><td align="left" valign="top" rowspan="1" colspan="1">15 (5.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Southern Province</td><td align="left" valign="top" rowspan="1" colspan="1">12 (5.3)</td><td align="left" valign="top" rowspan="1" colspan="1">4 (7.3)</td><td align="left" valign="top" rowspan="1" colspan="1">16 (5.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Occupational status</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Non-employed</td><td align="left" valign="top" rowspan="1" colspan="1">42 (18.5)</td><td align="left" valign="top" rowspan="1" colspan="1">12 (21.8)</td><td align="left" valign="top" rowspan="1" colspan="1">54 (19.1)</td><td align="left" valign="top" rowspan="1" colspan="1">0.575</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Employed</td><td align="left" valign="top" rowspan="1" colspan="1">185 (81.5)</td><td align="left" valign="top" rowspan="1" colspan="1">43 (78.2)</td><td align="left" valign="top" rowspan="1" colspan="1">228 (80.9)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Educational level</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Primary level</td><td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="left" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="left" valign="top" rowspan="1" colspan="1">1 (0.4)</td><td align="left" valign="top" rowspan="1" colspan="1">0.120</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Secondary level</td><td align="left" valign="top" rowspan="1" colspan="1">34 (15.0)</td><td align="left" valign="top" rowspan="1" colspan="1">9 (16.4)</td><td align="left" valign="top" rowspan="1" colspan="1">43 (15.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;University level</td><td align="left" valign="top" rowspan="1" colspan="1">193 (85.0)</td><td align="left" valign="top" rowspan="1" colspan="1">45 (81.8)</td><td align="left" valign="top" rowspan="1" colspan="1">238 (84.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Socioeconomic status</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Middle class</td><td align="left" valign="top" rowspan="1" colspan="1">3 (1.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="left" valign="top" rowspan="1" colspan="1">4 (1.4)</td><td align="left" valign="top" rowspan="1" colspan="1">0.408</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Rich</td><td align="left" valign="top" rowspan="1" colspan="1">219 (96.5)</td><td align="left" valign="top" rowspan="1" colspan="1">51 (92.7)</td><td align="left" valign="top" rowspan="1" colspan="1">270 (95.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Wealthiest</td><td align="left" valign="top" rowspan="1" colspan="1">5 (2.2)</td><td align="left" valign="top" rowspan="1" colspan="1">3 (5.5)</td><td align="left" valign="top" rowspan="1" colspan="1">8 (2.8)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;&lt;18.5</td><td align="left" valign="top" rowspan="1" colspan="1">3 (1.3)</td><td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="left" valign="top" rowspan="1" colspan="1">3 (1.1)</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;18.5&#8211;24.9</td><td align="left" valign="top" rowspan="1" colspan="1">79 (34.8)</td><td align="left" valign="top" rowspan="1" colspan="1">4 (7.3)</td><td align="left" valign="top" rowspan="1" colspan="1">83 (29.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;25&#8211;29.9</td><td align="left" valign="top" rowspan="1" colspan="1">72 (31.7)</td><td align="left" valign="top" rowspan="1" colspan="1">11 (20.0)</td><td align="left" valign="top" rowspan="1" colspan="1">83 (29.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;&gt;29.9</td><td align="left" valign="top" rowspan="1" colspan="1">73 (32.2)</td><td align="left" valign="top" rowspan="1" colspan="1">40 (72.7)</td><td align="left" valign="top" rowspan="1" colspan="1">113 (40.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn fn-type="abbr"><p>ANC, antenatal care; BMI, body mass index; GD, gestational diabetes; KFH, King Faisal Hospital.</p></fn></table-wrap-foot></table-wrap><p>In our data, while regional origin was not significantly associated with GDM in the adjusted model, examining this variable provides contextual insight into the distribution of risk factors across the population and helps ensure that urban-based findings are not overgeneralised. What is particularly noteworthy in this cohort is the high prevalence of overweight and obesity despite the participants&#8217; predominantly high socioeconomic and educational status (<xref rid="T2" ref-type="table">table 2</xref>).</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><title>Bivariate and multivariate binomial logistic regression analysis of the dependent variable GD to the predictor variables (socioeconomic demographic factors) of pregnant women who visited ANC from May 2023 to April 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" rowspan="1" colspan="1">Variables</th><th valign="bottom" rowspan="1" colspan="1">cRR</th><th valign="bottom" rowspan="1" colspan="1">P value</th><th valign="bottom" rowspan="1" colspan="1">95%&#8201;CI</th><th valign="bottom" rowspan="1" colspan="1">aRR</th><th valign="bottom" rowspan="1" colspan="1">95%&#8201;CI</th><th valign="bottom" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, years</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;&lt;24</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;24&#8211;34</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;&gt;34</td><td align="left" valign="top" rowspan="1" colspan="1">2.28</td><td align="left" valign="top" rowspan="1" colspan="1">1.2 to 4.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.006</td><td align="left" valign="top" rowspan="1" colspan="1">1.6</td><td align="left" valign="top" rowspan="1" colspan="1">0.85 to 2.98</td><td align="left" valign="top" rowspan="1" colspan="1">0.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Area of residence</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Kigali City</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Eastern Province</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Western Province</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Northern Province</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Southern Province</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">0.8 to 1.3</td><td align="left" valign="top" rowspan="1" colspan="1">0.57</td><td align="left" valign="top" rowspan="1" colspan="1">1.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.85 to 1.49</td><td align="left" valign="top" rowspan="1" colspan="1">0.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Occupation status</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">0.81</td><td align="left" valign="top" rowspan="1" colspan="1">0.39 to 1.67</td><td align="left" valign="top" rowspan="1" colspan="1">0.56</td><td align="left" valign="top" rowspan="1" colspan="1">1.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.41 to 2.48</td><td align="left" valign="top" rowspan="1" colspan="1">0.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Educational status</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Primary</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Secondary</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;University</td><td align="left" valign="top" rowspan="1" colspan="1">0.71</td><td align="left" valign="top" rowspan="1" colspan="1">0.34 to 1.49</td><td align="left" valign="top" rowspan="1" colspan="1">0.37</td><td align="left" valign="top" rowspan="1" colspan="1">0.51</td><td align="left" valign="top" rowspan="1" colspan="1">0.20 to 1.32</td><td align="left" valign="top" rowspan="1" colspan="1">0.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Socioeconomic status</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Middle class</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Rich</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Wealthiest</td><td align="left" valign="top" rowspan="1" colspan="1">1.85</td><td align="left" valign="top" rowspan="1" colspan="1">0.47 to 7.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.47</td><td align="left" valign="top" rowspan="1" colspan="1">1.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.30 to 5.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body mass index</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Underweight</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Normal weight</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Overweight</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Obese</td><td align="left" valign="top" rowspan="1" colspan="1">3.40</td><td align="left" valign="top" rowspan="1" colspan="1">2.1 to 5.4</td><td align="left" valign="top" rowspan="1" colspan="1">0.001</td><td align="left" valign="top" rowspan="1" colspan="1">3.2</td><td align="left" valign="top" rowspan="1" colspan="1">2.02 to 5.3</td><td align="left" valign="top" rowspan="1" colspan="1">0.002</td></tr></tbody></table><table-wrap-foot><fn id="T2_FN2" fn-type="other"><p>p&lt;0.05.</p></fn><fn id="T2_FN1" fn-type="abbr"><p>ANC, antenatal care; aRR, adjusted relative risk; cRR, crude relative risk; GD, gestational diabetes.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2"><title>GD cases and obstetric clinical characteristics of study participants</title><p>After screening using the 75&#8201;g OGTT, 55% (95% CI 41.9% to 68.4%) of participants diagnosed with GD had normal fasting blood glucose levels (&lt;92&#8201;mg/dL). In contrast, 44.5% (95% CI 31.5% to 58.0%) of patients with GD presented with elevated fasting glucose levels.</p><p>Among pregnant women diagnosed with GD, 21.4% had no identifiable risk factors, whereas 78.6% exhibited classical risk factors associated with the condition.</p><p>A history of fetal macrosomia was associated with a nearly fivefold increased risk of developing GD compared with those without such a history (aRR 4.9, 95%&#8201;CI 1.6 to 12.0; p=0.02). Similarly, participants with a family history of type 2 DM had approximately a fourfold increased risk of developing GD compared with those without such a history (aRR 4.6, 95%&#8201;CI 1.3 to 14.1; p=0.01) (<xref rid="T3" ref-type="table">table 3</xref>).</p><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3</label><caption><title>Bivariate and multivariate logistic binomial regression analysis of the dependent variable GD to the predictor variables (obstetric factors) of pregnant women who visited ANC from May 2023 to April 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" rowspan="1" colspan="1">Variables</th><th valign="bottom" rowspan="1" colspan="1">cRR</th><th valign="bottom" rowspan="1" colspan="1">95%&#8201;CI</th><th valign="bottom" rowspan="1" colspan="1">P value</th><th valign="bottom" rowspan="1" colspan="1">aRR</th><th valign="bottom" rowspan="1" colspan="1">95%&#8201;CI</th><th valign="bottom" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="7" rowspan="1">Parity</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Nullipara</td><td align="left" valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Primipara</td><td align="left" valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Multipara</td><td align="left" valign="top" rowspan="1" colspan="1">1.51</td><td valign="top" align="char" rowspan="1" colspan="1">1 to 2.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.019</td><td align="left" valign="top" rowspan="1" colspan="1">0.4</td><td align="left" valign="top" rowspan="1" colspan="1">0.25 to 0.92</td><td align="left" valign="top" rowspan="1" colspan="1">0.027</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">History of GD</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">11.06</td><td valign="top" align="char" rowspan="1" colspan="1">4.9 to 24</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">0.93</td><td align="left" valign="top" rowspan="1" colspan="1">0.16 to 5.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">Family history of type 2&#8201;DM</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">7</td><td valign="top" align="char" rowspan="1" colspan="1">2.8 to 17.4</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">4.6</td><td align="left" valign="top" rowspan="1" colspan="1">1.3 to 14.17</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">History of macrosomia</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">9.6</td><td valign="top" align="char" rowspan="1" colspan="1">2.7 to 33</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">4.9</td><td align="left" valign="top" rowspan="1" colspan="1">1.6 to 12</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">Unexpected fetal demise</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">19</td><td valign="top" align="char" rowspan="1" colspan="1">3.9 to 93</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">0.44</td><td align="left" valign="top" rowspan="1" colspan="1">0.21 to 9.4</td><td align="left" valign="top" rowspan="1" colspan="1">0.6</td></tr></tbody></table><table-wrap-foot><fn id="T3_FN2" fn-type="other"><p>p&lt;0.05 is considered significant.</p></fn><fn id="T3_FN1" fn-type="abbr"><p>ANC, antenatal care; aRR, adjusted relative risk; cRR, crude relative risk; DM, diabetes mellitus; GD, gestational diabetes.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-3"><title>Maternal/fetal outcomes</title><p>Pregnant women diagnosed with GD had a significantly higher risk of developing hypertensive disorders of pregnancy (HDP) compared with their non-GD counterparts. HDP occurred in 18.2% of women with GD and 4.7% of those without GD.</p><p>Similarly, caesarean deliveries were performed in 54.5% of the GD group compared with 19.4% of the non-GD group. PPH was also more common among women with GD (25.5%) than in 10.6% of non-GD cases (<xref rid="T4" ref-type="table">table 4</xref>).</p><table-wrap position="float" id="T4" orientation="portrait"><label>Table 4</label><caption><title>Bivariate and multivariate binomial logistic regression analysis for assessing the effects of GD on adverse maternal outcomes of pregnant women who visited ANC from May 2023 to April 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" rowspan="1" colspan="1">Variables</th><th valign="bottom" rowspan="1" colspan="1">cRR</th><th valign="bottom" rowspan="1" colspan="1">95%CI</th><th valign="bottom" rowspan="1" colspan="1">P value</th><th valign="bottom" rowspan="1" colspan="1">aRR</th><th valign="bottom" rowspan="1" colspan="1">95% CI</th><th valign="bottom" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="7" rowspan="1">HDP</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">3.9</td><td align="left" valign="top" rowspan="1" colspan="1">1.6 to 9.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">6.7</td><td align="left" valign="top" rowspan="1" colspan="1">7 to 26</td><td align="left" valign="top" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">IOL</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">2.3</td><td align="left" valign="top" rowspan="1" colspan="1">1.05 to 5.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">2.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.55 to 8.5</td><td align="left" valign="top" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">Operative vaginal delivery</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">2.7</td><td align="left" valign="top" rowspan="1" colspan="1">2.2 to 5.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">3.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.68 to 9.5</td><td align="left" valign="top" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">PTD</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">1.5</td><td align="left" valign="top" rowspan="1" colspan="1">1.01 to 4</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">0.52</td><td align="left" valign="top" rowspan="1" colspan="1">0.09 to 2.8</td><td align="left" valign="top" rowspan="1" colspan="1">0.45</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">PPH</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">6.1</td><td align="left" valign="top" rowspan="1" colspan="1">2.4 to 15</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">2.7 to 3.9</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">Polyhydramnios</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">3.9</td><td align="left" valign="top" rowspan="1" colspan="1">1.1 to 4.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">6.4</td><td align="left" valign="top" rowspan="1" colspan="1">1.94 to 8.9</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">Mode of delivery</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Vaginal</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Caesarean</td><td align="left" valign="top" rowspan="1" colspan="1">1.5</td><td align="left" valign="top" rowspan="1" colspan="1">1.1 to 3.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">4.9</td><td align="left" valign="top" rowspan="1" colspan="1">1.6 to 9.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.004</td></tr></tbody></table><table-wrap-foot><fn id="T4_FN2" fn-type="other"><p>p&lt;0.05 is considered significant.</p></fn><fn id="T4_FN1" fn-type="abbr"><p>ANC, antenatal care; aRR, adjusted relative risk; cRR, crude relative risk; GD, gestational diabetes; HDP, hypertensive disorder of pregnancy; IOL, induction of labor; PPH, postpartum haemorrhage; PTD, preterm delivery.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-4"><title>Neonatal outcomes</title><p>Newborns of mothers diagnosed with GD were more frequently admitted to NICU and more commonly developed neonatal hypoglycaemia than those born to non-GD mothers. In particular, NICU admissions occurred in 29% of neonates in the GD group vs 18% in the non-GD group, whereas the rate of neonatal hypoglycaemia was 22% in the GD group compared with 10% in the non-GD group. Both outcomes remained significantly associated with GD even after adjusting for potential confounders (<xref rid="T5" ref-type="table">table 5</xref>).</p><table-wrap position="float" id="T5" orientation="portrait"><label>Table 5</label><caption><title>Bivariate and multivariate binomial logistic regression analysis for assessing the effects of GD on adverse neonatal outcomes of pregnant women who visited ANC at KFH from May 2023 to April 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" rowspan="1" colspan="1">Variables</th><th valign="bottom" rowspan="1" colspan="1">cRR</th><th valign="bottom" rowspan="1" colspan="1">95%&#8201;CI</th><th valign="bottom" rowspan="1" colspan="1">P value</th><th valign="bottom" rowspan="1" colspan="1">aRR</th><th valign="bottom" rowspan="1" colspan="1">95%&#8201;CI</th><th valign="bottom" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="7" rowspan="1">NICU admission</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">1.5</td><td align="left" valign="top" rowspan="1" colspan="1">1.1 to 4.8</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">1.7</td><td align="left" valign="top" rowspan="1" colspan="1">1 to 4.6</td><td align="left" valign="top" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">Birth weight</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Low birth weight</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Normal birth weight</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Macrosomia</td><td align="left" valign="top" rowspan="1" colspan="1">1.4</td><td align="left" valign="top" rowspan="1" colspan="1">1.2 to 3.7</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">2.3</td><td align="left" valign="top" rowspan="1" colspan="1">1.01 to 3.5</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">Delivery time</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Premature</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Term</td><td align="left" valign="top" rowspan="1" colspan="1">0.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.03 to 2.02</td><td align="left" valign="top" rowspan="1" colspan="1">0.197</td><td align="left" valign="top" rowspan="1" colspan="1">0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.03 to 2.02</td><td align="left" valign="top" rowspan="1" colspan="1">0.197</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">Neonatal hypoglycaemia</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">2.1</td><td align="left" valign="top" rowspan="1" colspan="1">1.2 to 4.5</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">2.2</td><td align="left" valign="top" rowspan="1" colspan="1">1.2 to 4.5</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">APGAR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;No</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">0.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.005 to 1.9</td><td align="left" valign="top" rowspan="1" colspan="1">0.132</td><td align="left" valign="top" rowspan="1" colspan="1">0.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.005 to 1.9</td><td align="left" valign="top" rowspan="1" colspan="1">0.132</td></tr></tbody></table><table-wrap-foot><fn id="T5_FN2" fn-type="other"><p>p&lt;0.05 is considered significant; List of variables used to adjust this model are presented in this table.</p></fn><fn fn-type="abbr"><p>ANC, antenatal care; APGAR, Appearance Pulse Grimace Activity Respiration; aRR, adjusted relative risk; cRR, crude relative risk; GD, gestational diabetes; KFH, King Faisal Hospital; NICU, neonatal intensive care unit.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><sec id="s4-1"><title>Main findings</title><p>This prospective cohort study was conducted between May 2023 and April 2024. The cumulative incidence of GD among pregnant women screened at the KFH was found to be 19.5% (95% CI 15% to 24.6%) over an 8-month screening period with a 4-month follow-up. Of the 282&#8201;women who completed the study, 55 were diagnosed with GD. Notably, 55% of these GD patients had normal fasting blood glucose levels (&lt;92&#8201;mg/dL), underscoring the critical role of post-load glucose values in diagnosis. Although 78.6% of women diagnosed with GD presented with classical risk factors, 21.4% did not, indicating that relying solely on risk-based screening may have resulted in a considerable proportion of missed cases. Significant predictors of GD included increased BMI (aRR=3.2, p=0.002), a prior history of delivering a macrosomic infant (aRR 4.9, 95%&#8201;CI 1.6 to 12, p=0.02) and a family history of type 2 DM (aRR 4.6, 95%&#8201;CI 1.3 to 14.1, p=0.01). Furthermore, pregnant women diagnosed with GD were significantly more likely to experience adverse maternal outcomes. HDP occurred in 18.2% of women with GD compared with only 4.7% of those without GD. The caesarean delivery rate was also markedly higher among women with GD (54.5% vs 19.4%), reflecting the elevated risk profile associated with this condition. Additionally, PPH was more frequent in the GD group (25.5%) compared with the non-GD cohort (10.6).</p><p>In our cohort, newborns of mothers with GD experienced significantly worse neonatal outcomes than those born to non-GD mothers. Specifically, NICU admission occurred in 29% of neonates born to women with GD compared with 18% among those without GD, and neonatal hypoglycaemia was observed in 22% of neonates in the GD group versus 10% in the non-GD group. These findings emphasise the substantial maternal health burden associated with GD and the need for early identification and targeted management strategies.</p></sec><sec id="s4-2"><title>Interpretation of findings</title><p>These findings suggest a relatively high incidence of GD among the urban population of Rwanda. The majority of participants had high socioeconomic status, higher education and urban residence, factors often associated with a sedentary lifestyle and increased risk of metabolic disorders. The strong association between increased BMI and GD emphasises the importance of pre-pregnancy and early pregnancy weight optimisation. The substantial proportion of GD cases without traditional risk factors reinforces the value of universal screening, especially in settings with rising prevalence of non-communicable diseases. The significantly higher rates of HDP (18.2% vs 4.7%), caesarean delivery (54.5% vs 19.4%) and PPH (25.5% vs 10.6%) among women with GD underscore the substantial burden of maternal morbidity associated with this condition. Additionally, polyhydramnios was observed more frequently in the GD group (10.9% vs 3.5%), which may reflect the pathophysiological consequences of maternal hyperglycaemia on fetal fluid dynamics. After adjusting for potential confounders, both NICU admission and neonatal hypoglycaemia remained significantly associated with maternal GD, indicating that these associations are independent of other maternal or obstetric risk factors.</p></sec><sec id="s4-3"><title>Comparison with existing literature</title><p>The cumulative incidence rate was 19.5%. Our results were similar to those of a study conducted in Goma, Democratic Republic of Congo (21.2%). The current findings showed increased incidence compared with the study conducted in our health centres in Rwanda (4.2%), Arusha, Tanzania (13%), Goba Town, Ethiopia (15.7%), in Africa (14%) and the world (14.7%).<xref rid="R1" ref-type="bibr">13</xref><xref rid="R12" ref-type="bibr">5 11 12</xref></p><p>Regarding cumulative incidence rate, we found that it was lower in St Francis in Uganda (29.4%) and South East Asia (25%).<xref rid="R3" ref-type="bibr"><sup>3</sup></xref></p><p>The screening of GD in this study was universal; however, by performing selective screening based on classic risk factors, up to 21.4%&#8201;cases can be missed. A study conducted at St Francis in Uganda (23.8%) and in Ethiopia revealed that up to 45%&#8201;cases could be missed by using this approach.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref></p><p>Results from the multivariate binomial logistic model adjusted for potential confounders showed that women with higher BMI (aRR=3.2, p=0.002), family history of type 2 DM (aRR=4.6, p=0.01), and a previous baby with macrosomia (aRR=4.9, p=0.02) had an increased risk for developing GD compared with non-GD cases, which was comparable to the findings of research conducted in Goba Town, Ethiopia and Goma, Eastern Democratic Republic of Congo.<xref rid="R1" ref-type="bibr"><sup>1 12</sup></xref></p><p>Women with GD had a higher risk of hypertensive disorders, polyhydramnios, caesarean delivery and PPH than those without GD. These results were consistent with studies conducted in Gondar, Ethiopia and Uganda, where the risk of hypertensive disorders was also elevated, while other maternal outcomes were similarly affected in both the GD and non-GD groups.<xref rid="R13" ref-type="bibr"><sup>13 14</sup></xref></p><p>There was no association between preterm delivery, operative vaginal delivery, unexplained fetal demise and maternal death: these findings were similar to those of the study conducted at St. Francis in Uganda and in urban areas of Uganda.<xref rid="R13" ref-type="bibr"><sup>13 14</sup></xref></p><p>The risk of macrosomia, neonatal hypoglycaemia and NICU admission was increased in participants with GD compared with those without GD in this study; in a study conducted in urban areas of Uganda, findings were similar in terms of macrosomia and neonatal hypoglycaemia.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref></p><p>The study is the first to be conducted in Rwanda to investigate the relationship between GD and negative outcomes for mothers, fetuses and newborns. This was a prospective study with a response rate of 95%. The screening for GD was conducted in accordance with the WHO 2013 guidelines, and venous blood samples were immediately analysed after collection for the diagnosis of GD.</p><p>However, the study has a few limitations; we did not have data of prepregnancy BMI of the participant, and to generalise our results to the general population, we need to conduct this study in other health facilities of the country.</p></sec></sec><sec sec-type="conclusions" id="s5"><title>Conclusions</title><p>An increased incidence rate of GD was observed at the KFH. We observed that a high BMI is an independent risk factor, and education about diet and exercise is a key intervention.</p><p>We found that GD is associated with demographic and obstetric factors that can lead to adverse maternal and neonatal outcomes. After adjusting for confounders, we found that the risk of GD was increased in women with a higher BMI, a previous baby with macrosomia and a family history of type 2 DM.</p><p>We have seen that GD independently increased the risk of adverse maternal outcomes such as HDP, polyhydramnios, caesarean delivery, PPH and the risk of neonatal adverse outcomes such as NICU admission, hypoglycaemia and macrosomia, compared with non-GD cases.</p><p>There are currently no specific screening methods for GD in Rwanda. We recommend a cross-sectional survey of GD across the country to investigate the burden and the risk factors of GD to accordingly frame national guidelines for screening for GD by the Ministry of Health and implement.</p><p>We recommend that decision-makers at KFH can use our findings for screening, diagnosing and prevention of GD.</p></sec></body><back><ack><title>Acknowledgements</title><p>EN, MM specialist at Kigali Teaching Hospital, Rwanda, is the principal investigator of this research and was involved in the conception, design, data interpretation, and manuscript preparation. We thank all authors: BKN; MM specialist, AA, Medical Epidemiologist at the University of Global Health Equity, Rwanda; GJG, MM specialist, San Diego, California, USA; SM, Obstetrician and Gynaecologist at King Faisal Hospital, Rwanda; VN, Fetal Medicine Specialist at King Faisal Hospital, Rwanda; HG, Fetal Medicine Specialist at Rwanda Military Hospital, Rwanda; SG, Obstetrician and Gynaecologist at King Faisal Hospital, Rwanda; FT, MM specialist at Kigali Teaching Hospital, Rwanda; BS, Fetal Medicine Specialist at Rwanda Military Hospital, Rwanda; MM, Obstetrician and Gynaecologist at King Faisal Hospital, Rwanda; and JPB, Obstetrician and Gynaecologist at King Faisal Hospital, Rwanda, for their contributions to the study design, data analysis, and interpretation. BKN, AA and GJG also contributed to the final version of the manuscript.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> EN received a grant from King Faisal Foundation for data collection and analysis. The project was funded by King Faisal Hospital Foundation (grant number: KFH/249).</p></fn><fn fn-type="other"><p>Prepublication history for this paper is available online. To view these files, please visit the journal online (<ext-link xlink:href="https://doi.org/10.1136/bmjopen-2024-098248" ext-link-type="uri">https://doi.org/10.1136/bmjopen-2024-098248</ext-link>).</p></fn><fn fn-type="other"><p><bold>Patient consent for publication:</bold> Consent obtained directly from patient(s).</p></fn><fn fn-type="other"><p><bold>Ethics approval:</bold> The study protocol was reviewed and approved by the Institutional Review Board of the College of Medicine and Health Sciences, University of Rwanda (Reference No. 230/CMHS IRB/2023). The principal investigator ensured the confidentiality and anonymity of all study participants. Each participant was assigned a unique identification code, and all data were deidentified prior to entry. No information identifying individual respondents was presented in the study. Hard copy data were securely stored in a locked cabinet accessible only to the principal investigator, while electronic data were stored in a password-protected folder on the principal investigator&#8217;s personal computer. These data will be destroyed 1 year after the publication of the study results.</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Patient and public involvement:</bold> Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atlaw</surname><given-names>D</given-names></name><name name-style="western"><surname>Sahiledengle</surname><given-names>B</given-names></name><name name-style="western"><surname>Assefa</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>Incidence and risk factors of gestational diabetes mellitus in Goba town, Southeast Ethiopia: a prospective cohort study</article-title><source>BMJ Open</source><year>2022</year><volume>12</volume><elocation-id>e060694</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2021-060694</pub-id><pub-id pub-id-type="pmcid">PMC9516079</pub-id><pub-id pub-id-type="pmid">36167396</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>The HAPO Study Cooperative Research Group</collab></person-group><source>Hyperglycemia and Adverse Pregnancy Outcomes</source><year>2008</year><comment>Available</comment><ext-link xlink:href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa0707943" ext-link-type="uri">https://www.nejm.org/doi/pdf/10.1056/NEJMoa0707943</ext-link></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Betty</surname><given-names>N</given-names></name><name name-style="western"><surname>Silver</surname><given-names>B</given-names></name><name name-style="western"><surname>Romano</surname><given-names>B</given-names></name></person-group><article-title>Prevalence of hyperglycemia first detected during pregnancy and subsequent obstetric outcomes at St. Francis Hospital Nsambya</article-title><source>BMC</source><year>2017</year><pub-id pub-id-type="doi">10.1186/s13104-017-2493-0</pub-id><pub-id pub-id-type="pmcid">PMC5414152</pub-id><pub-id pub-id-type="pmid">28464913</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maryam</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><name name-style="western"><surname>Helen</surname><given-names>F</given-names></name><etal>et al</etal></person-group><article-title>Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG Criteria: a systematic review and meta-analysis</article-title><source>Diab Res Clin Pract</source><year>2021</year><pub-id pub-id-type="doi">10.1016/j.diabres.2020.108642</pub-id><pub-id pub-id-type="pmid">33359574</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Achenef</surname><given-names>A</given-names></name><name name-style="western"><surname>Oladapo</surname><given-names>O</given-names></name><name name-style="western"><surname>Yigzaw</surname><given-names>K</given-names></name></person-group><article-title>Data from Prevalence and determinants of gestational diabetes mellitus in Africa based on the updated international diagnostic criteria: a systematic review and meta-analysis</article-title><source>Arch Public Health</source><year>2019</year><pub-id pub-id-type="doi">10.1186/s13690-019-0362-0</pub-id><pub-id pub-id-type="pmcid">PMC6683510</pub-id><pub-id pub-id-type="pmid">31402976</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Msollo</surname><given-names>SS</given-names></name><name name-style="western"><surname>Martin</surname><given-names>HD</given-names></name><name name-style="western"><surname>Mwanri</surname><given-names>AW</given-names></name><etal>et al</etal></person-group><article-title>Prevalence of hyperglycemia in pregnancy and influence of body fat on development of hyperglycemia in pregnancy among pregnant women in urban areas of Arusha region, Tanzania</article-title><source><italic toggle="yes">BMC Pregnancy Childbirth</italic></source><year>2019</year><volume>19</volume><pub-id pub-id-type="doi">10.1186/s12884-019-2463-8</pub-id><pub-id pub-id-type="pmcid">PMC6712730</pub-id><pub-id pub-id-type="pmid">31455272</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mwanri</surname><given-names>AW</given-names></name><name name-style="western"><surname>Kinabo</surname><given-names>J</given-names></name><name name-style="western"><surname>Ramaiya</surname><given-names>K</given-names></name><etal>et al</etal></person-group><article-title>Prevalence of gestational diabetes mellitus in urban and rural Tanzania</article-title><source>Diabetes Res Clin Pract</source><year>2014</year><volume>103</volume><fpage>71</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2013.11.021</pub-id><pub-id pub-id-type="pmid">24367971</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Punder</surname><given-names>K</given-names></name><name name-style="western"><surname>Pruimboom</surname><given-names>L</given-names></name></person-group><article-title>The dietary intake of wheat and other cereal grains and their role in inflammation</article-title><source>Nutrients</source><year>2013</year><volume>5</volume><fpage>771</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.3390/nu5030771</pub-id><pub-id pub-id-type="pmid">23482055</pub-id><pub-id pub-id-type="pmcid">PMC3705319</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muhihi</surname><given-names>A</given-names></name><name name-style="western"><surname>Gimbi</surname><given-names>D</given-names></name><name name-style="western"><surname>Njelekela</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Consumption and acceptability of whole grain staples for lowering markers of diabetes risk among overweight and obese Tanzanian adults</article-title><source>Global Health</source><year>2013</year><volume>9</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.1186/1744-8603-9-26</pub-id><pub-id pub-id-type="pmid">23800295</pub-id><pub-id pub-id-type="pmcid">PMC3704955</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krige</surname><given-names>SM</given-names></name><name name-style="western"><surname>Booley</surname><given-names>S</given-names></name><name name-style="western"><surname>Levitt</surname><given-names>NS</given-names></name><etal>et al</etal></person-group><article-title>Dietary Intake and Beliefs of Pregnant Women with Gestational Diabetes in Cape Town, South Africa</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><fpage>1183</fpage><pub-id pub-id-type="doi">10.3390/nu10091183</pub-id><pub-id pub-id-type="pmid">30154387</pub-id><pub-id pub-id-type="pmcid">PMC6164942</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meharry</surname><given-names>PM</given-names></name><name name-style="western"><surname>Tengera</surname><given-names>O</given-names></name><name name-style="western"><surname>Rulisa</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Prevalence of gestational diabetes mellitus among women attending antenatal care at public health centers in Rwanda</article-title><source>Diabetes Res Clin Pract</source><year>2019</year><volume>151</volume><fpage>252</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2019.03.035</pub-id><pub-id pub-id-type="pmid">30946850</pub-id><pub-id pub-id-type="pmcid">PMC6941349</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kisindja</surname><given-names>RM</given-names></name><name name-style="western"><surname>Tugirimana</surname><given-names>PL</given-names></name><name name-style="western"><surname>Prudence</surname><given-names>MN</given-names></name><etal>et al</etal></person-group><article-title>Prevalence of gestational diabetes in Eastern Democratic Republic of Congo</article-title><source>BMC Pregnancy Childbirth</source><year>2022</year><volume>22</volume><elocation-id>645</elocation-id><pub-id pub-id-type="doi">10.1186/s12884-022-04970-y</pub-id><pub-id pub-id-type="pmid">35974333</pub-id><pub-id pub-id-type="pmcid">PMC9380361</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muche</surname><given-names>AA</given-names></name><name name-style="western"><surname>Olayemi</surname><given-names>OO</given-names></name><name name-style="western"><surname>Gete</surname><given-names>YK</given-names></name></person-group><article-title>Effects of gestational diabetes mellitus on risk of adverse maternal outcomes: a prospective cohort study in Northwest Ethiopia</article-title><source>BMC Pregnancy Childbirth</source><year>2020</year><volume>20</volume><elocation-id>73</elocation-id><pub-id pub-id-type="doi">10.1186/s12884-020-2759-8</pub-id><pub-id pub-id-type="pmid">32013909</pub-id><pub-id pub-id-type="pmcid">PMC6998275</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milln</surname><given-names>J</given-names></name><name name-style="western"><surname>Nakabuye</surname><given-names>B</given-names></name><name name-style="western"><surname>Natamba</surname><given-names>BK</given-names></name><etal>et al</etal></person-group><article-title>Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study</article-title><source>BMC Pregnancy Childbirth</source><year>2021</year><volume>21</volume><elocation-id>386</elocation-id><pub-id pub-id-type="doi">10.1186/s12884-021-03795-5</pub-id><pub-id pub-id-type="pmid">34011299</pub-id><pub-id pub-id-type="pmcid">PMC8132348</pub-id></element-citation></ref></ref-list><sec sec-type="data-availability"><title>Data availability statement</title><p>All data relevant to the study are included in the article or uploaded as supplementary information.</p></sec></back><sub-article id="sub-article1" article-type="aggregated-review-documents"><front-stub><title-group><article-title>Review Process File</article-title></title-group><pub-date pub-type="epub"><day>31</day><month>08</month><year>2025</year></pub-date></front-stub><body><fig id="d67e2081" position="anchor" orientation="portrait"><media xlink:href="bmjopen-2024-098248.reviewer_comments.pdf" position="float" orientation="portrait"/></fig></body></sub-article></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>